已收盘 07-02 16:00:00 美东时间
+2.000
+5.00%
今日重点评级关注:Chardan Capital:维持EyePoint"买入"评级,目标价从29美元升至65美元;康托·菲茨杰拉德:维持Hyperliquid Strategies"超配"评级,目标价从8美元升至18.4美元
07-02 18:41
Goldman Sachs analyst Robert Cox maintains Ryan Specialty Holdings (NYSE:RYAN) with a Neutral and raises the price target from $35 to $40.
07-01 19:33
今日重点评级关注:花旗:维持Shattuck Labs"买入"评级,目标价从7美元升至18美元;Benchmark:维持Gloo Holdings"买入"评级,目标价从14美元升至15美元
06-10 12:32
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.25美元升至5.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9美元升至9.25美元
06-09 11:33
Goldman Sachs analyst Robert Cox downgrades Ryan Specialty Holdings (NYSE:RYAN) from Buy to Neutral and lowers the price target from $42 to $35.
06-09 01:17
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx药业"超配"评级,目标价从84美元升至96美元;Ascendiant Capital:维持Liqtech国际"买入"评级,目标价从4.3美元升至4.4美元
05-22 10:18
Morgan Stanley analyst Bob Huang maintains Ryan Specialty Holdings (NYSE:RYAN) with a Overweight and lowers the price target from $45 to $39.
05-21 21:06
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on Hormuz news and Trump set 25% EU auto tariffs.
05-02 01:11